FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dik Kwekkeboom

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Single-Photon Emission-Computed Tomography

Co-author Network

Publications

TOP 3
Caroline D M Witjes; Robert A de Man; Roy S Dwarkasing; Dik J Kwekkeboom; Cornelis Verhoef; Jan N M Ijzermans
Is bone scintigraphy indicated in surgical work-up for hepatocellular carcinoma patients?
Esther I van Vliet; Jaap J M Teunissen; Marion De Jong; Boen L Kam; Eric P Krenning; Dik J Kwekkeboom
Treatment of gastroenteropancreatic neuroendocrine tumors with peptide receptor radionuclide therapy.
Hendrik Bergsma; Wouter W de Herder; Boen L Kam; Eric P Krenning; Robin P Peeters; Jaap J M Teunissen; Esther I van Vliet; Dik J Kwekkeboom
Peptide receptor radionuclide therapy (PRRT) for GEP-NETs.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dik Kwekkeboom (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Caroline D M Witjes; Robert A de Man; Roy S Dwarkasing; Dik J Kwekkeboom; Cornelis Verhoef; Jan N M Ijzermans
Is bone scintigraphy indicated in surgical work-up for hepatocellular carcinoma patients?
The Journal of surgical research 2013;181(2):256-61.
2013: Esther I van Vliet; Jaap J M Teunissen; Marion De Jong; Boen L Kam; Eric P Krenning; Dik J Kwekkeboom
Treatment of gastroenteropancreatic neuroendocrine tumors with peptide receptor radionuclide therapy.
Neuroendocrinology 2013;97(1):74-85.
2012: Hendrik Bergsma; Wouter W de Herder; Boen L Kam; Eric P Krenning; Robin P Peeters; Jaap J M Teunissen; Esther I van Vliet; Dik J Kwekkeboom
Peptide receptor radionuclide therapy (PRRT) for GEP-NETs.
Best practice & research. Clinical gastroenterology 2012;26(6):867-81.
2012: Esther I van Vliet; Jaap J M Teunissen; Ronald R de Krijger; Maria A de Ridder; John J Hermans; Boen L Kam; Eric P Krenning; Dik J Kwekkeboom
Tumor response assessment to treatment with [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors: differential response of bone versus soft-tissue lesions.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2012;53(9):1359-66.
2012: Stoffel F J Van Eeckhoudt; Jaap J M Teunissen; Dik J Kwekkeboom
Increased mammary uptake on 111In pentetreotide scintigraphy.
Clinical nuclear medicine 2012;37(8):781-2.
2012: Dik J Kwekkeboom
Therapy: Neuroendocrine cancer--are two radionuclides better than one?
Nature reviews. Endocrinology 2012;8(6):326-8.
2012: Boen L Kam; S Khan; Eric P Krenning; Jaap J M Teunissen; E I van Vliet; Wouter W de Herder; Dik J Kwekkeboom
Lutetium-labelled peptides for therapy of neuroendocrine tumours.
European journal of nuclear medicine and molecular imaging 2012;39 Suppl 1():S103-12.
2012: Gianfranco Delle Fave; Ulrich Knigge; Beata Kos-Kudla; Dik J Kwekkeboom; Guido Rindi; Philippe Ruszniewski; Ramon Salazar; Hironobu Sasano; Paola Tomassetti; Erik Van Cutsem
ENETS Consensus Guidelines for the management of patients with gastroduodenal neoplasms.
Neuroendocrinology 2012;95(2):74-87.
2011: Lieke S Kamphuis; Robert W Kuijpers; Dik J Kwekkeboom; Wai-Kwan Lam-Tse; Paula van Biezen; Paul L van Daele; G Seerp Baarsma; Jeroen Bastiaans; Willem A Dik; Herbert Hooijkaas; Jan A van Laar; P Martin van Hagen
Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis.
American journal of respiratory and critical care medicine 2011;184(10):1214-6.
2011: E van Schaik; E I van Vliet; Richard A Feelders; K Kamp; S Khan; Eric P Krenning; Dik J Kwekkeboom; Jaap J M Teunissen; Roelf Valkema; Francien H van Nederveen; Wouter W de Herder
Improved control of severe hypoglycemia in patients with malignant insulinomas by peptide receptor radionuclide therapy.
The Journal of clinical endocrinology and metabolism 2011;96(11):3381-9.
2011: Jaap J M Teunissen; Roelf Valkema; Dik J Kwekkeboom; Eric P Krenning
Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.
Endocrine-related cancer 2011;18 Suppl 1():S27-51.
2011: Saima Khan; Eric P Krenning; Jaap J M Teunissen; Martijn van Essen; Boen L Kam; Dik J Kwekkeboom
Quality of life in 265 patients with gastroenteropancreatic or bronchial neuroendocrine tumors treated with [177Lu-DOTA0,Tyr3]octreotate.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(9):1361-8.
2011: Wouter A P Breeman; Erik De Blois; Ho Sze Chan; Mark Konijnenberg; Dik J Kwekkeboom; Eric P Krenning
(68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.
Seminars in nuclear medicine 2011;41(4):314-21.
2011: Dik J Kwekkeboom; Wouter W de Herder; Eric P Krenning
Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors.
Endocrinology and metabolism clinics of North America 2011;40(1):173-85, ix.
2010: Kjell E Oberg; Jean-Claude Reubi; Dik J Kwekkeboom; Eric P Krenning
Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapy.
Gastroenterology 2010;139(3):742-53, 753.e1.
2010: Stefan E Pool; Eric P Krenning; Gerben A Koning; C H J van Eijck; Jaap J M Teunissen; Boen L Kam; Roelf Valkema; Dik J Kwekkeboom; Marion De Jong
Preclinical and clinical studies of peptide receptor radionuclide therapy.
Seminars in nuclear medicine 2010;40(3):209-18.
2010: Martijn van Essen; Eric P Krenning; Boen L Kam; Wouter W de Herder; Richard A Feelders; Dik J Kwekkeboom
Salvage therapy with (177)Lu-octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2010;51(3):383-90.
2010: Dik J Kwekkeboom; Wouter W de Herder; C H J van Eijck; Boen L Kam; Martijn van Essen; Jaap J M Teunissen; Eric P Krenning
Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors.
Seminars in nuclear medicine 2010;40(2):78-88.
2010: Dik J Kwekkeboom; Boen L Kam; Martijn van Essen; Jaap J M Teunissen; C H J van Eijck; Roelf Valkema; Marion De Jong; Wouter W de Herder; Eric P Krenning
Somatostatin-receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors.
Endocrine-related cancer 2010;17(1):R53-73.
2009: Jaap J M Teunissen; Eric P Krenning; Frank de Jong; Yolanda B De Rijke; Richard A Feelders; Maarten O van Aken; Wouter W de Herder; Dik J Kwekkeboom
Effects of therapy with [177Lu-DOTA 0,Tyr 3]octreotate on endocrine function.
European journal of nuclear medicine and molecular imaging 2009;36(11):1758-66.
2009: Marion De Jong; Wouter A P Breeman; Dik J Kwekkeboom; Roelf Valkema; Eric P Krenning
Tumor imaging and therapy using radiolabeled somatostatin analogues.
Accounts of chemical research 2009;42(7):873-80.
2009: Martijn van Essen; Eric P Krenning; Boen L Kam; Marion De Jong; Roelf Valkema; Dik J Kwekkeboom
Peptide-receptor radionuclide therapy for endocrine tumors.
Nature reviews. Endocrinology 2009;5(7):382-93.
2009: Flavio Forrer; Eric P Krenning; Peter P M Kooij; Bert F Bernard; Mark W Konijnenberg; Willem H Bakker; Jaap J M Teunissen; Marion De Jong; Kirsten van Lom; Wouter W de Herder; Dik J Kwekkeboom
Bone marrow dosimetry in peptide receptor radionuclide therapy with [177Lu-DOTA(0),Tyr(3)]octreotate.
European journal of nuclear medicine and molecular imaging 2009;36(7):1138-46.
2009: Dik J Kwekkeboom; Eric P Krenning; Rachida Lebtahi; Paul Komminoth; Beata Kos-Kudła; Wouter W de Herder; Ursula Plöckinger
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: peptide receptor radionuclide therapy with radiolabeled somatostatin analogs.
Neuroendocrinology 2009;90(2):220-6.
2009: Dik J Kwekkeboom; Eric P Krenning; Klemens Scheidhauer; Val Lewington; Rachida Lebtahi; Ashley Grossman; Pavel Vitek; Anders Sundin; Ursula Plöckinger
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: somatostatin receptor imaging with (111)In-pentetreotide.
Neuroendocrinology 2009;90(2):184-9.
2008: Dik J Kwekkeboom; Wouter W de Herder; Boen L Kam; C H J van Eijck; Martijn van Essen; Peter P M Kooij; Richard A Feelders; Maarten O van Aken; Eric P Krenning
Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(13):2124-30.
2008: Aejaz Nasir; Nancy M Gardner; Jonathan Strosberg; Nazeel Ahmad; Junsung Choi; Mokenge P Malafa; Domenico Coppola; Dik J Kwekkeboom; Jaap J M Teunissen; Larry K Kvols
Multimodality management of a polyfunctional pancreatic endocrine carcinoma with markedly elevated serum vasoactive intestinal polypeptide and calcitonin levels.
Pancreas 2008;36(3):309-13.
2008: Bart de Keizer; Maarten O van Aken; Richard A Feelders; Wouter W de Herder; Boen L Kam; Martijn van Essen; Eric P Krenning; Dik J Kwekkeboom
Hormonal crises following receptor radionuclide therapy with the radiolabeled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate.
European journal of nuclear medicine and molecular imaging 2008;35(4):749-55.
2008: Martijn van Essen; Eric P Krenning; Boen L Kam; Wouter W de Herder; Maarten O van Aken; Dik J Kwekkeboom
Report on short-term side effects of treatments with 177Lu-octreotate in combination with capecitabine in seven patients with gastroenteropancreatic neuroendocrine tumours.
European journal of nuclear medicine and molecular imaging 2008;35(4):743-8.
2008: Thomas Steinmüller; Reza Kianmanesh; Massimo Falconi; Aldo Scarpa; Babs Taal; Dik J Kwekkeboom; José M Lopes; Aurel Perren; George Nikou; James Yao; Gian Franco Delle Fave; Dermot O'Toole
Consensus guidelines for the management of patients with liver metastases from digestive (neuro)endocrine tumors: foregut, midgut, hindgut, and unknown primary.
Neuroendocrinology 2008;87(1):47-62.
2007: Martijn van Essen; Eric P Krenning; Willem H Bakker; Wouter W de Herder; Maarten O van Aken; Dik J Kwekkeboom
Peptide receptor radionuclide therapy with 177Lu-octreotate in patients with foregut carcinoid tumours of bronchial, gastric and thymic origin.
European journal of nuclear medicine and molecular imaging 2007;34(8):1219-27.
2007: Dik J Kwekkeboom; Jaap J M Teunissen; Boen L Kam; Roelf Valkema; Wouter W de Herder; Eric P Krenning
Treatment of patients who have endocrine gastroenteropancreatic tumors with radiolabeled somatostatin analogues.
Hematology/oncology clinics of North America 2007;21(3):561-73; x.
2007: Wouter A P Breeman; Dik J Kwekkeboom; Erik De Blois; Marion De Jong; Theo J Visser; Eric P Krenning
Radiolabelled regulatory peptides for imaging and therapy.
Anti-cancer agents in medicinal chemistry 2007;7(3):345-57.
2007: Wouter W de Herder; Ambroos E M Reijs; Richard A Feelders; Maarten O van Aken; Eric P Krenning; Aart Jan Van der Lely; Dik J Kwekkeboom
Diagnostic imaging of dopamine receptors in pituitary adenomas.
European journal of endocrinology / European Federation of Endocrine Societies 2007;156 Suppl 1():S53-6.
2007: Flavio Forrer; Roelf Valkema; Dik J Kwekkeboom; Marion De Jong; Eric P Krenning
Neuroendocrine tumors. Peptide receptor radionuclide therapy.
Best practice & research. Clinical endocrinology & metabolism 2007;21(1):111-29.
2007: Martijn van Essen; Eric P Krenning; Marion De Jong; Roelf Valkema; Dik J Kwekkeboom
Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours.
Acta oncologica (Stockholm, Sweden) 2007;46(6):723-34.
2006: Willem H Bakker; Wouter A P Breeman; Dik J Kwekkeboom; L C De Jong; Eric P Krenning
Practical aspects of peptide receptor radionuclide therapy with [177Lu][DOTA0, Tyr3]octreotate.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of Radiopharmaceutical Chemistry and Biology 2006;50(4):265-71.
2006: Wouter W de Herder; Ambroos E M Reijs; Richard A Feelders; Maarten O van Aken; Eric P Krenning; Hervé L J Tanghe; Aart Jan Van der Lely; Dik J Kwekkeboom
Dopamine agonist therapy of clinically non-functioning pituitary macroadenomas. Is there a role for 123I-epidepride dopamine D2 receptor imaging?
European journal of endocrinology / European Federation of Endocrine Societies 2006;155(5):717-23.
2006: Jan-Paul Esser; Eric P Krenning; Jaap J M Teunissen; Peter P M Kooij; Arthur van Gameren; Willem H Bakker; Dik J Kwekkeboom
Comparison of [(177)Lu-DOTA(0),Tyr(3)]octreotate and [(177)Lu-DOTA(0),Tyr(3)]octreotide: which peptide is preferable for PRRT?
European journal of nuclear medicine and molecular imaging 2006;33(11):1346-51.
2006: Edgar J Rolleman; Marion De Jong; Roelf Valkema; Dik J Kwekkeboom; Boen L Kam; Eric P Krenning
Inhibition of kidney uptake of radiolabeled somatostatin analogs: amino acids or gelofusine?
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(10):1730-1; author reply 1731.
2006: Martijn van Essen; Eric P Krenning; Peter P M Kooij; Willem H Bakker; Richard A Feelders; Wouter W de Herder; John G Wolbers; Dik J Kwekkeboom
Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(10):1599-606.
2006: Roelf Valkema; Stanislas Pauwels; Larry K Kvols; Raffaella Barone; François Jamar; Willem H Bakker; Dik J Kwekkeboom; Hakim Bouterfa; Eric P Krenning
Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors.
Seminars in nuclear medicine 2006;36(2):147-56.
2006: Ola Nilsson; Erik Van Cutsem; Gianfranco Delle Fave; James C Yao; Marianne E Pavel; Anne McNicol; M I Sevilla Garcia; WH Knapp; Fahrettin Keleştimur; Alain Sauvanet; Stanislas Pauwels; Dik J Kwekkeboom; Martyn E Caplin
Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic).
Neuroendocrinology 2006;84(3):212-5.
2006: Massimo Falconi; Ursula Plockinger; Dik J Kwekkeboom; Riccardo Manfredi; Meike Korner; Larry K Kvols; Ulrich F Pape; Jens Ricke; Peter E Goretzki; Stefan Wildi; Thomas Steinmuller; Kjell Oberg; Jean-Yves Scoazec
Well-differentiated pancreatic nonfunctioning tumors/carcinoma.
Neuroendocrinology 2006;84(3):196-211.
2006: Wouter W de Herder; Bruno Niederle; Jean-Yves Scoazec; Stanislas Pauwels; Gunter Kloppel; Massimo Falconi; Dik J Kwekkeboom; Kjel Oberg; Barbro Eriksson; Bertram Wiedenmann; Guido Rindi; Dermot O'Toole; Diego Ferone
Well-differentiated pancreatic tumor/carcinoma: insulinoma.
Neuroendocrinology 2006;84(3):183-8.
2006: Robert T Jensen; Guido Rindi; Rudolf Arnold; José M Lopes; Maria Luisa Brandi; Wolf Bechstein; Emanuel Christ; Babs G Taal; Ulrich Knigge; Håkan Ahlman; Dik J Kwekkeboom; Dermot O'Toole
Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas).
Neuroendocrinology 2006;84(3):165-72.
2006: Philippe Ruszniewski; Gianfranco Delle Fave; Guillaume Cadiot; Paul Komminoth; Daniel Chung; Beata Kos-Kudla; Reza Kianmanesh; David Hochhauser; Rudolf Arnold; Håkan Ahlman; Stanislas Pauwels; Dik J Kwekkeboom; Guido Rindi
Well-differentiated gastric tumors/carcinomas.
Neuroendocrinology 2006;84(3):158-64.
2006: Wouter W de Herder; Dik J Kwekkeboom; Richard A Feelders; Maarten O van Aken; Steven W J Lamberts; Aart Jan Van der Lely; Eric P Krenning
Somatostatin receptor imaging for neuroendocrine tumors.
Pituitary 2006;9(3):243-8.
2006: Jaap J M Teunissen; Dik J Kwekkeboom; Eric P Krenning
Staging and treatment of differentiated thyroid carcinoma with radiolabeled somatostatin analogs.
Trends in endocrinology and metabolism: TEM 2006;17(1):19-25.
2005: Jaap J M Teunissen; Dik J Kwekkeboom; Marion De Jong; Jan-Paul Esser; Roelf Valkema; Eric P Krenning
Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy.
Best practice & research. Clinical gastroenterology 2005;19(4):595-616.
2005: Dik J Kwekkeboom; Jaap J M Teunissen; Willem H Bakker; Peter P M Kooij; Wouter W de Herder; Richard A Feelders; C H J van Eijck; Jan-Paul Esser; Boen L Kam; Eric P Krenning
Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(12):2754-62.
2005: Eric P Krenning; Jaap J M Teunissen; Roelf Valkema; W W deHerder; M deJong; Dik J Kwekkeboom
Molecular radiotherapy with somatostatin analogs for (neuro-)endocrine tumors.
Journal of endocrinological investigation 2005;28(11 Suppl International):146-50.
2005: Wouter W de Herder; Dik J Kwekkeboom; R Valkema; Richard A Feelders; Maarten O van Aken; Steven W J Lamberts; Aart Jan Van der Lely; E P Krenning
Neuroendocrine tumors and somatostatin: imaging techniques.
Journal of endocrinological investigation 2005;28(11 Suppl International):132-6.
2005: Jaap J M Teunissen; Dik J Kwekkeboom; Peter P M Kooij; Willem H Bakker; Eric P Krenning
Peptide receptor radionuclide therapy for non-radioiodine-avid differentiated thyroid carcinoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():107S-14S.
2005: Roelf Valkema; Stanislas Pauwels; Larry K Kvols; Dik J Kwekkeboom; François Jamar; Marion De Jong; Raffaella Barone; stephan walrand; Peter P M Kooij; Willem H Bakker; Janet Lasher; Eric P Krenning
Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():83S-91S.
2005: Eric P Krenning; Roelf Valkema; Dik J Kwekkeboom; Wouter W de Herder; C H J van Eijck; Marion De Jong; Stanislas Pauwels; Jean Claude Reubi
Molecular imaging as in vivo molecular pathology for gastroenteropancreatic neuroendocrine tumors: implications for follow-up after therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():76S-82S.
2005: Dik J Kwekkeboom; Jan Mueller-Brand; Giovanni Paganelli; Lowell Anthony; Stanislas Pauwels; Larry K Kvols; Thomas M O'dorisio; Roelf Valkema; Lisa Bodei; Marco Chinol; Helmut R Maecke; Eric P Krenning
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2005;46 Suppl 1():62S-6S.
2004: Jaap J M Teunissen; Dik J Kwekkeboom; Eric P Krenning
Quality of life in patients with gastroenteropancreatic tumors treated with [177Lu-DOTA0,Tyr3]octreotate.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(13):2724-9.
2004: Eric P Krenning; Dik J Kwekkeboom; Roelf Valkema; Stanislas Pauwels; Larry K Kvols; Marion De Jong
Peptide receptor radionuclide therapy.
Annals of the New York Academy of Sciences 2004;1014():234-45.
2003: Lisa Bodei; Leo J Hofland; Diego Ferone; Cornelia M Mooy; Johan M Kros; Dion Paridaens; Seerp G Baarsma; Marco Ferdeghini; Martin P van Hagen; Eric P Krenning; Dik J Kwekkeboom
In vivo and in vitro detection of dopamine d2 receptors in uveal melanomas.
Cancer biotherapy & radiopharmaceuticals 2003;18(6):895-902.
2003: Jan-Paul Esser; H Yoe Oei; Dik J Kwekkeboom; Eric P Krenning
Diffuse lung and stomach uptake of Tc-99m oxidronate (HDP).
Clinical nuclear medicine 2003;28(10):845-6.
2003: Aart Jan Van der Lely; Wouter W de Herder; Eric P Krenning; Dik J Kwekkeboom
Octreoscan radioreceptor imaging.
Endocrine 2003;20(3):307-11.
2003: Dik J Kwekkeboom; Willem H Bakker; Boen L Kam; Jaap J M Teunissen; Peter P M Kooij; Wouter W de Herder; Richard A Feelders; C H J van Eijck; Marion De Jong; Ananth Srinivasan; Jack Erion; Eric P Krenning
Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate.
European journal of nuclear medicine and molecular imaging 2003;30(3):417-22.
2003: Marion De Jong; Dik J Kwekkeboom; Roelf Valkema; Eric P Krenning
Radiolabelled peptides for tumour therapy: current status and future directions. Plenary lecture at the EANM 2002.
European journal of nuclear medicine and molecular imaging 2003;30(3):463-9.
2002: Wouter A P Breeman; Marion De Jong; Jack Erion; Joseph E Bugaj; Ananth Srinivasan; Bert F Bernard; Dik J Kwekkeboom; Theo J Visser; Eric P Krenning
Preclinical comparison of (111)In-labeled DTPA- or DOTA-bombesin analogs for receptor-targeted scintigraphy and radionuclide therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(12):1650-6.
2002: Marion De Jong; Roelf Valkema; François Jamar; Larry K Kvols; Dik J Kwekkeboom; Wouter A P Breeman; Willem H Bakker; Chuck Smith; Stanislas Pauwels; Eric P Krenning
Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings.
Seminars in nuclear medicine 2002;32(2):133-40.
2002: Dik J Kwekkeboom; Eric P Krenning
Somatostatin receptor imaging.
Seminars in nuclear medicine 2002;32(2):84-91.
2001: Wouter A P Breeman; Marion De Jong; Dik J Kwekkeboom; Roelf Valkema; Willem H Bakker; Peter P M Kooij; Theo J Visser; Eric P Krenning
Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives.
European journal of nuclear medicine 2001;28(9):1421-9.
2001: Dik J Kwekkeboom; Willem H Bakker; Peter P M Kooij; M W Konijnenberg; Ananth Srinivasan; Jack Erion; Michelle A Schmidt; J L Bugaj; Marion De Jong; Eric P Krenning
[177Lu-DOTAOTyr3]octreotate: comparison with [111In-DTPAo]octreotide in patients.
European journal of nuclear medicine 2001;28(9):1319-25.
2001: Diego Ferone; Dik J Kwekkeboom; Rosario Pivonello; A Bogers ADColao; Steven W J Lamberts; P Martin van Hagen; Leo J Hofland
In vivo and in vitro expression of somatostatin receptors in two human thymomas with similar clinical presentation and different histological features.
Journal of endocrinological investigation 2001;24(7):522-8.
2001: L M Haslinghuis; Eric P Krenning; Wouter W de Herder; Ambroos E M Reijs; Dik J Kwekkeboom
Somatostatin receptor scintigraphy in the follow-up of patients with differentiated thyroid cancer.
Journal of endocrinological investigation 2001;24(6):415-22.
2000: Dik J Kwekkeboom; P Martin van Hagen; Eric P Krenning
Refractory immune-mediated and haematological diseases: candidates for peptide receptor radiotherapy?
European journal of endocrinology / European Federation of Endocrine Societies 2000;143 Suppl 1():S53-6.
2000: Dik J Kwekkeboom; Eric P Krenning; Marion De Jong
Peptide receptor imaging and therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2000;41(10):1704-13.
2000: Dik J Kwekkeboom; Willem H Bakker; Peter P M Kooij; Jack Erion; Ananth Srinivasan; Marion De Jong; Jean Claude Reubi; Eric P Krenning
Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma.
European journal of nuclear medicine 2000;27(9):1312-7.
2000: A C Fröberg; Wouter W de Herder; H Jaap Bonjer; Eric P Krenning; H Yoe Oei; Dik J Kwekkeboom
Tc-99m sestamibi before and during treatment in a patient with sarcoidosis and persistent hyperparathyroidism.
Clinical nuclear medicine 2000;25(5):351-3.
2000: Diego Ferone; Martin P van Hagen; Dik J Kwekkeboom; Peter M Van Koetsveld; Diana M Mooy; Elgin G R Lichtenauer-Kaligis; A Schönbrunn; Annamaria Colao; Steven W J Lamberts; Leo J Hofland
Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro.
The Journal of clinical endocrinology and metabolism 2000;85(4):1719-26.
2000: Eric P Krenning; Roelf Valkema; Peter P M Kooij; Wouter A P Breeman; Willem H Bakker; Wouter W de Herder; C H J van Eijck; Dik J Kwekkeboom; Marion De Jong; François Jamar; Stanislas Pauwels
The role of radioactive somatostatin and its analogues in the control of tumor growth.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2000;153():1-13.
1999: Marion De Jong; Wouter A P Breeman; H F Bernard; Peter P M Kooij; Gerrit D Slooter; C H J van Eijck; Dik J Kwekkeboom; Roelf Valkema; Helmut R Mäcke; Eric P Krenning
Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1999;43(4):356-66.
1999: Marion De Jong; Willem H Bakker; Bert F Bernard; Roelf Valkema; Dik J Kwekkeboom; Jean Claude Reubi; Ananth Srinivasan; Michelle Schmidt; Eric P Krenning
Preclinical and initial clinical evaluation of 111In-labeled nonsulfated CCK8 analog: a peptide for CCK-B receptor-targeted scintigraphy and radionuclide therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(12):2081-7.
1999: Wouter A P Breeman; Marion De Jong; Bert F Bernard; Dik J Kwekkeboom; Ananth Srinivasan; ME van der Pluijm; Leo Hofland; Theo J Visser; Eric P Krenning
Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphy.
International journal of cancer. Journal international du cancer 1999;83(5):657-63.
1999: Eric P Krenning; Roelf Valkema; Peter P M Kooij; Wouter A P Breeman; Willem H Bakker; W W deHerder; C H vanEijck; Dik J Kwekkeboom; M deJong; Stanislas Pauwels
Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotide.
Italian journal of gastroenterology and hepatology 1999;31 Suppl 2():S219-23.
1999: P Martin van Hagen; Leo J Hofland; Annemieke M.C. ten Bokum; Elgin G R Lichtenauer-Kaligis; Dik J Kwekkeboom; Diego Ferone; Steven W J Lamberts
Neuropeptides and their receptors in the immune system.
Annals of medicine 1999;31 Suppl 2():15-22.
1999: Annemieke M.C. ten Bokum; Leo J Hofland; G de Jong; J Bouma; Marie-José Melief; Dik J Kwekkeboom; A Schonbrunn; Cornelia M Mooy; Jon D Laman; Steven W J Lamberts; P Martin van Hagen
Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomas.
European journal of clinical investigation 1999;29(7):630-6.
1999: Wouter A P Breeman; Leo Hofland; Marion De Jong; Bert F Bernard; Ananth Srinivasan; Dik J Kwekkeboom; Theo J Visser; Eric P Krenning
Evaluation of radiolabelled bombesin analogues for receptor-targeted scintigraphy and radiotherapy.
International journal of cancer. Journal international du cancer 1999;81(4):658-65.
1999: Dik J Kwekkeboom; Peter P M Kooij; Willem H Bakker; Helmut R Mäcke; Eric P Krenning
Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptake.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1999;40(5):762-7.
1999: Eric P Krenning; Marion De Jong; Peter P M Kooij; Wouter A P Breeman; Willem H Bakker; Wouter W de Herder; C H J van Eijck; Dik J Kwekkeboom; François Jamar; Stanislas Pauwels; Roelf Valkema
Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10 Suppl 2():S23-9.
1999: Dik J Kwekkeboom; Wouter W de Herder; Eric P Krenning
Receptor imaging in the diagnosis and treatment of pituitary tumors.
Journal of endocrinological investigation 1999;22(1):80-8.
1999: Wouter W de Herder; Ambroos E M Reijs; J de Swart; Y Kaandorp; Steven W J Lamberts; Eric P Krenning; Dik J Kwekkeboom
Comparison of iodine-123 epidepride and iodine-123 IBZM for dopamine D2 receptor imaging in clinically non-functioning pituitary macroadenomas and macroprolactinomas.
European journal of nuclear medicine 1999;26(1):46-50.
1998: Dik J Kwekkeboom; Eric P Krenning; G S Kho; Wouter A P Breeman; P Martin van Hagen
Somatostatin receptor imaging in patients with sarcoidosis.
European journal of nuclear medicine 1998;25(9):1284-92.
1998: C H J van Eijck; Dik J Kwekkeboom; E P Krenning
Somatostatin receptors and breast cancer.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1998;42(1):18-25.
1998: Wouter A P Breeman; P Martin van Hagen; Dik J Kwekkeboom; Theo J Visser; Eric P Krenning
Somatostatin receptor scintigraphy using [111In-DTPA0]RC-160 in humans: a comparison with [111In-DTPA0]octreotide.
European journal of nuclear medicine 1998;25(2):182-6.
1997: Wouter A P Breeman; Marion De Jong; Bert F Bernard; Willem H Bakker; Edgar J Rolleman; Dik J Kwekkeboom; Theo J Visser; Eric P Krenning
Effects of ligand priming and multiple-dose injection on tissue uptake of 111In-pentetreotide in rats.
Nuclear medicine and biology 1997;24(8):749-53.
1997: Dik J Kwekkeboom; Eric P Krenning
Radiolabeled somatostatin analog scintigraphy in oncology and immune diseases: an overview.
European radiology 1997;7(7):1103-9.
1996: Wouter W de Herder; Ambroos E M Reijs; Dik J Kwekkeboom; Leo Hofland; FR Nobels; H Y Oei; Eric P Krenning; Steven W J Lamberts
In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligand.
Clinical endocrinology 1996;45(6):755-67.
1996: P Martin van Hagen; Wouter A P Breeman; J C Reubi; P T Postema; P J van den Anker-Lugtenburg; Dik J Kwekkeboom; Jean A Laissue; Beatrice Waser; Steven W J Lamberts; Theo J Visser; Eric P Krenning
Visualization of the thymus by substance P receptor scintigraphy in man.
European journal of nuclear medicine 1996;23(11):1508-13.
1996: Wouter A P Breeman; Willem H Bakker; Marion De Jong; Leo Hofland; Dik J Kwekkeboom; Peter P M Kooij; Theo J Visser; Eric P Krenning
Studies on radiolabeled somatostatin analogues in rats and in patients.
The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR) 1996;40(3):209-20.
1996: Willem Klootwijk; Wouter W de Herder; Dik J Kwekkeboom; Steven W J Lamberts; Eric P Krenning; Theo J Visser; WJ de Greef
High serum levels of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in patients with carcinoid tumors.
The Journal of clinical endocrinology and metabolism 1996;81(8):2816-20.
1996: Dik J Kwekkeboom; Steven W J Lamberts; J D Habbema; Eric P Krenning
Cost-effectiveness analysis of somatostatin receptor scintigraphy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(6):886-92.
1996: P T Postema; Dik J Kwekkeboom; P Martin van Hagen; Eric P Krenning
Somatostatin-receptor scintigraphy in Graves' orbitopathy.
European journal of nuclear medicine 1996;23(6):615-7.
1996: Dik J Kwekkeboom; Eric P Krenning
Somatostatin receptor scintigraphy in patients with carcinoid tumors.
World journal of surgery 1996;20(2):157-61.
1996: Eric P Krenning; Peter P M Kooij; Stanislas Pauwels; Wouter A P Breeman; P T Postema; Wouter W de Herder; Roelf Valkema; Dik J Kwekkeboom
Somatostatin receptor: scintigraphy and radionuclide therapy.
Digestion 1996;57 Suppl 1():57-61.
1996: P T Postema; Wouter W de Herder; J C Reubi; H Y Oei; Dik J Kwekkeboom; H J Bruining; J Bonjer; Hans van Toor; Georg Hennemann; Eric P Krenning
Somatostatin receptor scintigraphy in non-medullary thyroid cancer.
Digestion 1996;57 Suppl 1():36-7.
1996: Wouter A P Breeman; M P VanHagen; H A Visser-Wisselaar; ME van der Pluijm; Jan W Koper; B Setyono-Han; Willem H Bakker; Dik J Kwekkeboom; M P Hazenberg; Steven W J Lamberts; Theo J Visser; Eric P Krenning
In vitro and in vivo studies of substance P receptor expression in rats with the new analog [indium-111-DTPA-Arg1]substance P.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1996;37(1):108-17.
1995: Wouter A P Breeman; Dik J Kwekkeboom; Peter P M Kooij; Willem H Bakker; Leo Hofland; Theo J Visser; G J Ensing; Steven W J Lamberts; Eric P Krenning
Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in rats.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1995;36(4):623-7.
1994: FR Nobels; Wouter W de Herder; Dik J Kwekkeboom; W Coopmans; A Mulder; R Bouillon; Steven W J Lamberts
Serum chromogranin A in the differential diagnosis of Cushing's syndrome.
European journal of endocrinology / European Federation of Endocrine Societies 1994;131(6):589-93.
1994: Eric P Krenning; Dik J Kwekkeboom; Marion De Jong; Theo J Visser; J C Reubi; Willem H Bakker; Peter P M Kooij; Steven W J Lamberts
Essentials of peptide receptor scintigraphy with emphasis on the somatostatin analog octreotide.
Seminars in oncology 1994;21(5 Suppl 13):6-14.
1994: P M Vanhagen; H M Markusse; Steven W J Lamberts; Dik J Kwekkeboom; J C Reubi; Eric P Krenning
Somatostatin receptor imaging. The presence of somatostatin receptors in rheumatoid arthritis.
Arthritis and rheumatism 1994;37(10):1521-7.
1994: Dik J Kwekkeboom; G S Kho; Steven W J Lamberts; J C Reubi; Jean Laissue; Eric P Krenning
The value of octreotide scintigraphy in patients with lung cancer.
European journal of nuclear medicine 1994;21(10):1106-13.
1994: Eric P Krenning; Peter P M Kooij; Willem H Bakker; Wouter A P Breeman; P T Postema; Dik J Kwekkeboom; H Y Oei; Marion De Jong; Theo J Visser; Ambroos E M Reijs
Radiotherapy with a radiolabeled somatostatin analogue, [111In-DTPA-D-Phe1]-octreotide. A case history.
Annals of the New York Academy of Sciences 1994;733():496-506.
1994: Eric P Krenning; Dik J Kwekkeboom; H Y Oei; R J de Jong; F J Dop; J C Reubi; Steven W J Lamberts
Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results.
Annals of the New York Academy of Sciences 1994;733():416-24.
1994: P M Vanhagen; Eric P Krenning; J C Reubi; Dik J Kwekkeboom; Willem H Bakker; A H Mulder; I Laissue; H C Hoogstede; Steven W J Lamberts
Somatostatin analogue scintigraphy in granulomatous diseases.
European journal of nuclear medicine 1994;21(6):497-502.
1994: Wouter W de Herder; Eric P Krenning; C D Malchoff; Leo Hofland; J C Reubi; Dik J Kwekkeboom; H Y Oei; H A Pols; Hajo A Bruining; FR Nobels
Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion.
The American journal of medicine 1994;96(4):305-12.
1994: Wouter A P Breeman; Leo Hofland; ME van der Pluijm; Peter M Van Koetsveld; Marion De Jong; B Setyono-Han; Willem H Bakker; Dik J Kwekkeboom; Theo J Visser; Steven W J Lamberts
A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
European journal of nuclear medicine 1994;21(4):328-35.
1994: P Martin van Hagen; Eric P Krenning; Dik J Kwekkeboom; J C Reubi; P J Anker-Lugtenburg; Bob Löwenberg; Steven W J Lamberts
Somatostatin and the immune and haematopoetic system; a review.
European journal of clinical investigation 1994;24(2):91-9.
1994: Eric P Krenning; Dik J Kwekkeboom; H Y Oei; R J de Jong; F J Dop; Wouter W de Herder; J C Reubi; Steven W J Lamberts
Somatostatin receptor scintigraphy in carcinoids, gastrinomas and Cushing's syndrome.
Digestion 1994;55 Suppl 3():54-9.
1993: Wouter A P Breeman; Leo Hofland; Willem H Bakker; ME van der Pluijm; Peter M Van Koetsveld; Marion De Jong; B Setyono-Han; Dik J Kwekkeboom; Theo J Visser; Steven W J Lamberts
Radioiodinated somatostatin analogue RC-160: preparation, biological activity, in vivo application in rats and comparison with [123I-Tyr3]octreotide.
European journal of nuclear medicine 1993;20(11):1089-94.
1993: FR Nobels; Dik J Kwekkeboom; W Coopmans; R Hoekstra; Wouter W de Herder; R Bouillon; Steven W J Lamberts
A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas.
The Journal of clinical endocrinology and metabolism 1993;77(3):784-9.
1993: Eric P Krenning; Dik J Kwekkeboom; Willem H Bakker; Wouter A P Breeman; Peter P M Kooij; H Y Oei; M van Hagen; P T Postema; Marion De Jong; J C Reubi
Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.
European journal of nuclear medicine 1993;20(8):716-31.
1993: Dik J Kwekkeboom; J Assies; Leo Hofland; J C Reubi; Steven W J Lamberts; Eric P Krenning
A case of antibody formation against octreotide visualized with 111In-octreotide scintigraphy.
Clinical endocrinology 1993;39(2):239-43; discussion 244.
1993: Steven W J Lamberts; Wouter W de Herder; Dik J Kwekkeboom; A J vd Lely; FR Nobels; Eric P Krenning
Current tools in the diagnosis of pituitary tumours.
Acta endocrinologica 1993;129 Suppl 1():6-12.
1993: Dik J Kwekkeboom; J C Reubi; Steven W J Lamberts; Hajo A Bruining; A H Mulder; H Y Oei; Eric P Krenning
In vivo somatostatin receptor imaging in medullary thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 1993;76(6):1413-7.
1993: Dik J Kwekkeboom; H van Urk; B K Pauw; Steven W J Lamberts; Peter P M Kooij; R P Hoogma; Eric P Krenning
Octreotide scintigraphy for the detection of paragangliomas.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1993;34(6):873-8.
1993: Dik J Kwekkeboom; Eric P Krenning; Willem H Bakker; H Y Oei; Peter P M Kooij; Steven W J Lamberts
Somatostatin analogue scintigraphy in carcinoid tumours.
European journal of nuclear medicine 1993;20(4):283-92.
1993: Eric P Krenning; Dik J Kwekkeboom; J C Reubi; P Martin van Hagen; C H J van Eijck; H Y Oei; Steven W J Lamberts
111In-octreotide scintigraphy in oncology.
Digestion 1993;54 Suppl 1():84-7.
1993: Steven W J Lamberts; Leo Hofland; Wouter W de Herder; Dik J Kwekkeboom; J C Reubi; Eric P Krenning
Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy.
Frontiers in neuroendocrinology 1993;14(1):27-55.
1992: Eric P Krenning; Dik J Kwekkeboom; J C Reubi; P Martin van Hagen; C H J van Eijck; H Y Oei; Steven W J Lamberts
111In-octreotide scintigraphy in oncology.
Metabolism: clinical and experimental 1992;41(9 Suppl 2):83-6.
1992: FR Nobels; Dik J Kwekkeboom; Wouter W de Herder; Steven W J Lamberts
[Clinically non-functioning hypophyseal adenomas; diagnostic possibilities and therapeutic options].
Nederlands tijdschrift voor geneeskunde 1992;136(24):1148-52.
1992: Dik J Kwekkeboom; A M Hoff; Steven W J Lamberts; H Y Oei; Eric P Krenning
Somatostatin analogue scintigraphy. A simple and sensitive method for the in vivo visualization of Merkel cell tumors and their metastases.
Archives of dermatology 1992;128(6):818-21.
1992: Eric P Krenning; Willem H Bakker; Peter P M Kooij; Wouter A P Breeman; H Y Oei; Marion De Jong; J C Reubi; Theo J Visser; Christian Bruns; Dik J Kwekkeboom
Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(5):652-8.
1992: Eric P Krenning; Dik J Kwekkeboom; H Y Oei; J C Reubi; P Martin van Hagen; Peter P M Kooij; Ambroos E M Reijs; Steven W J Lamberts
Somatostatin receptor imaging of endocrine gastrointestinal tumors.
Schweizerische medizinische Wochenschrift 1992;122(17):634-7.
1992: Jan W Koper; R Markstein; C Kohler; Dik J Kwekkeboom; Cees J J Avezaat; Steven W J Lamberts; J C Reubi
Somatostatin inhibits the activity of adenylate cyclase in cultured human meningioma cells and stimulates their growth.
The Journal of clinical endocrinology and metabolism 1992;74(3):543-7.
1991: Dik J Kwekkeboom; Eric P Krenning; Willem H Bakker; H Y Oei; T A Splinter; G S Kho; Steven W J Lamberts
Radioiodinated somatostatin analog scintigraphy in small-cell lung cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(10):1845-8.
1990: Dik J Kwekkeboom; Leo Hofland; Peter M Van Koetsveld; R Singh; J H van den Berge; Steven W J Lamberts
Bromocriptine increasingly suppresses the in vitro gonadotropin and alpha-subunit release from pituitary adenomas during long term culture.
The Journal of clinical endocrinology and metabolism 1990;71(3):718-24.
1990: Dik J Kwekkeboom; Steven W J Lamberts; J H Blom; F H Schroeder; Frank de Jong
Prolonged treatment with the GnRH analogue buserelin does not affect alpha-subunit production by the pituitary gonadotroph.
Clinical endocrinology 1990;32(4):443-51.
1990: Dik J Kwekkeboom; Frank de Jong; A M van Hemert; J P Vandenbroucke; H A Valkenburg; Steven W J Lamberts
Serum gonadotropins and alpha-subunit decline in aging normal postmenopausal women.
The Journal of clinical endocrinology and metabolism 1990;70(4):944-50.
1989: Dik J Kwekkeboom; Frank de Jong; Steven W J Lamberts
Confounding factors in the interpretation of gonadotropin and gonadotropin-subunit release from cultured human pituitary adenomas.
Journal of steroid biochemistry 1989;33(4B):777-82.
1989: Dik J Kwekkeboom; Frank de Jong; Steven W J Lamberts
Gonadotropin release by clinically nonfunctioning and gonadotroph pituitary adenomas in vivo and in vitro: relation to sex and effects of thyrotropin-releasing hormone, gonadotropin-releasing hormone, and bromocriptine.
The Journal of clinical endocrinology and metabolism 1989;68(6):1128-35.
1989: J H Blom; W H Hirdes; Fritz H Schröder; Frank de Jong; Dik J Kwekkeboom; A J van't Veen; Juergen Sandow; B Krauss
Pharmacokinetics and endocrine effects of the LHR analogue buserelin after subcutaneous implantation of a slow release preparation in prostatic cancer patients.
Urological research 1989;17(1):43-6.